创金合信全球医药生物股票发起(QDII)A(018155)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2025/12/31 |
9,334,790 |
61,160,200 |
71,750,900 |
19,925,500 |
51,825,400 |
555.19% |
| 2025/9/30 |
6,228,740 |
9,334,790 |
4,693,100 |
1,587,050 |
3,106,050 |
49.87% |
| 2025/6/30 |
6,795,520 |
6,228,740 |
2,056,280 |
2,623,060 |
-566,780 |
-8.34% |
| 2025/6/30 |
6,301,860 |
6,228,740 |
727,043 |
800,162 |
-73,119 |
-1.16% |
| 2025/3/31 |
6,795,520 |
6,301,860 |
1,329,240 |
1,822,900 |
-493,660 |
-7.26% |
| 2024/12/31 |
5,342,620 |
6,795,520 |
2,883,980 |
1,431,080 |
1,452,900 |
27.19% |
| 2024/12/31 |
6,325,590 |
6,795,520 |
1,492,030 |
1,022,100 |
469,930 |
7.43% |
| 2024/9/30 |
6,200,100 |
6,325,590 |
267,527 |
142,036 |
125,491 |
2.02% |
| 2024/6/30 |
5,342,620 |
6,200,100 |
1,124,420 |
266,941 |
857,479 |
16.05% |
| 2024/6/30 |
6,287,150 |
6,200,100 |
160,554 |
247,607 |
-87,053 |
-1.38% |
| 2024/3/31 |
5,342,620 |
6,287,150 |
963,864 |
19,334 |
944,530 |
17.68% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
